Skip to main content
. Author manuscript; available in PMC: 2016 Oct 3.
Published in final edited form as: Histopathology. 2011 Jul;59(1):63–72. doi: 10.1111/j.1365-2559.2011.03892.x

Table 2.

Association between Skil and DAB2 protein levels and clinical parameters

Variables Skil, P-value DAB2, P-value
Age 0.438104 0.31167
Stage 0.496313 0.214462
Tumour size 0.695067 0.026841
LVI 0.454003 0.193674
MI 0.351787 0.361266
Grade (FIGO) 0.202524 0.000484
Grade (nuclear) 0.357179 0.000883
Subtype 0.144599 0.000244
Recurrence 0.454003 0.193674
DFS 0.11452 0.039739

DFS, Disease-free survival; FIGO, International Federation of Gynecology and Obstetrics; LVI, lymphovascular invasion; MI, myometrial invasion.

The P-values are for Fisher's exact test, for testing the associations between protein levels of Skil and DAB2 and the clinical parameters. For this analysis, we considered the cut-off for each of the variables as follows. Age: group 1 (G1) <65 years; group 2 (G2) ≥65 years. Stage: G1, stage I and II; G2, stage III and IV. Tumour size: G1, ≤20 mm; G2, >20 mm. LVI: G1, absent; G2, present. MI: G1 ≤50%; G2, >50%. Grade: G1, grade 1 and 2; G2, grade 3. Histological subtype: G1, clear cell carcinoma (CCC) and serous; G2, endometrioid subtype. Recurrence: G1, negative; G2, positive. Status: G1, DFS; G2, all other outcomes.